Document:

Exhibit 10.1

 

 

Amended
and restated

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
Amended and Restated Executive Employment Agreement (“Agreement”) is made as of November 1, 2021, by and between Michael
B. Arouh (“Executive”) and GAN Nevada, Inc., including its Affiliates (collectively, the “Company”)
and Executive and Company shall be referred to herein, collectively, as the “Parties” and, individually, as a “Party.”

 

RECITALS

 

WHEREAS,
the Parties previously executed one or more offer letters, employment agreements, letters, and if applicable, amendments thereto (collectively,
the “Prior Agreement”);

 

WHEREAS,
the Company desires to employ Executive on the terms set forth herein;

 

WHEREAS,
Executive desires to be employed by the Company on such terms and conditions;

 

WHEREAS,
for purposes of Executive’s employment with the Company, Executive agrees Executive is an executive and officer of the Company;

 

WHEREAS,
the Company may provide Executive with the Company’s Confidential Information and may also provide the opportunity to develop relationships
with the Company’s business contacts;

 

WHEREAS,
Executive agrees that if Executive receives the foregoing, it may give Executive an unfair competitive advantage if Executive’s
activities during employment, and for a reasonable period thereafter, were not restricted as provided for in this Agreement; and

 

WHEREAS,
the Parties intend for this Agreement to supersede and replace any agreement, offer letter, promise, representation, or understanding
between the Parties regarding Executive’s employment with the Company, including, but not limited to, the Prior Agreement (for
the avoidance of doubt, this Agreement does not supersede equity grants or equity award agreements).

 

NOW,
THEREFORE, in consideration of the mutual promises made herein, the adequacy and sufficiency of which are hereby acknowledged, the
Parties, intending to be legally bound, hereby agree as follows:

 

1.
At-Will Employment. Executive’s employment with the Company is, and has always been, at-will. To that end, Executive’s
employment with the Company is not for a specified term. Executive has the right to resign from Executive’s employment with the
Company at any time, with or without notice to the Company with or without cause. The Company also is free to terminate Executive’s
employment with the Company at any time, with or without notice to Executive and with or without cause.

 

2.
Position and Duties.

 

a.
Duties. The Company’s Board of Directors (the “Board”) has ratified the appointment of,
and hereby employs Executive as, the Company’s “Chief Legal Officer” (an exempt position). During Executive’s
employment with Company (“Executive’s Employment”), Executive shall report directly to the Company’s Chief
Executive Officer (the “CEO”). In such a position, Executive’s duties, authority and responsibilities shall
include, but will not be limited to, those customary and commensurate with Executive’s position. Additionally, Executive’s
duties, authority, and responsibilities shall be determined from time to time by the CEO, provided that such duties, authority, and responsibilities
are consistent with Executive’s position.

 

b.
Devotion of Time. During Executive’s Employment, Executive shall devote substantially all of Executive’s
business time and attention to the performance of Executive’s duties hereunder and will not engage in any other business, profession,
or occupation for compensation or otherwise which would conflict or interfere with the performance of such services either directly or
indirectly without the prior written consent of the CEO.

 

    	Page 1 of 22

     

    

 

3.
Place of Performance. The principal place of Executive’s employment shall be remote, unless mutually agreed otherwise
by you and the Company (expected to be in the United States eastern time zone) (“Principal Place of Business”), provided
that Executive may be required to travel on Company business during Executive’s employment with the Company. If the Company requests
Executive to relocate more than 30 miles, and if Executive agrees to such request, then the Company will pay for Executive’s reasonable
and necessary costs of relocation (e.g., moving expenses, real estate commissions, and fees incurred in selling a home, temporary
lodging, and airfare).

 

4.
Compensation and Equity Rights.

 

a.
Base Salary. The Company shall pay Executive a salary equivalent to an annual salary of $290,000, which the Company
shall pay to Executive in periodic installments in accordance with the Company’s customary payroll practices and applicable wage
payment laws. Executive’s salary set forth in this section and as in effect from time to time, is hereinafter referred to as “Base
Salary.”

 

b.
Target Bonus. Executive shall be eligible to earn an annual target bonus equal to (i) 100% of Executive’s
Base Salary actually paid to executive for calendar year 2021, and (ii) 75% of Executive’s Base Salary actually paid to Executive
for each calendar year thereafter (the “Target Bonus”), as determined by the Compensation Committee of the Board (the
“Compensation Committee”), based 50% upon the Company’s performance, with such Company performance goals to
be set annually in good faith by the Compensation Committee, and 50% upon Executive meeting certain specific performance objectives to
be defined by the CEO in consultation with the Compensation Committee and Executive. Notwithstanding the forgoing, (1) Executive shall
be deemed to have earned the Target Bonus so long as all of the following conditions have been satisfied: (i) Executive remains employed
with the Company through the end of the year in which the applicable Target Bonus is based, (ii) Executive does not voluntarily terminate
Executive’s Employment (other than for Good Reason) prior to the payment of the Target Bonus, and (iii) Executive is materially
in compliance with this Agreement. The Company shall pay Executive the Target Bonus within 90 calendar days following the end of the
Company’s applicable fiscal year. Notwithstanding the foregoing, (i) up to 50% of Executive’s Bonus for calendar year 2021,
and (ii) up to one third (1/3) of Executive’s Bonus in subsequent years, may be paid through the issuance of restricted stock units
(“RSUs”), subject to the terms of the applicable Award Agreement (as defined below). Any RSUs issued in lieu of a
cash Bonus hereunder will vest in two equal semi-annual tranches.

 

c.
Equity. The Company has established a 2020 Equity Incentive Plan (the “Plan”) that was
adopted on or about May 4, 2020, which is attached hereto as Exhibit A and incorporated by reference. Executive shall be eligible
to receive, but not guaranteed, equity awards under the Plan (“Equity Awards”) pursuant to form agreements that describe,
among other things, the vesting schedule, strike price (if applicable), expiration date, and other terms, all of which are incorporated
herein by reference (each an “Award Agreement”). For each calendar year commencing in the year following the year
in which the Effective Date occurs, but not later than March 31 of each such year, Executive will be eligible, to receive, but not guaranteed,
an annual grant of RSUs or other form of equity grant under an Award Agreement in an amount established by the Chief Executive Officer,
in consultation with the Company’s Compensation Committee.

 

d.
Expenses. Executive shall be entitled to reimbursement for reasonable and necessary out-of-pocket business, entertainment,
and travel expenses, all gaming license fees and expenses related to the preparation and submission of gaming license applications that
may be required by Executive’s position and law license fees and expenses (collectively, “Business Expenses”)
incurred by Executive in connection with the performance of Executive’s duties hereunder, provided that, Executive complies with
the Company’s expense reimbursement policies and procedures then in effect.

 

    	Page 2 of 22

     

    

 

e.
Benefits. Executive shall be entitled to participate in all executive benefit plans, practices, and programs maintained
by the Company, as in effect from time to time (collectively, “Executive Benefit Plans”), to the extent consistent
with applicable law and the terms of the applicable Executive Benefit Plans. The Company reserves the right to amend or cancel any Executive
Benefit Plans at any time in its sole discretion, subject to the terms of such Executive Benefit Plan and applicable law. If the Board
determines that the Company should purchase a “key-man” insurance policy on the life of Executive, then Executive agrees
to submit to any requested physical examination in connection with the Company or any affiliate’s purchase of such a key-man insurance
policy, and Executive agrees to cooperate fully in connection with the underwriting, purchase and/or retention of any such key-man insurance
policy by the Company or any of its affiliates. The terms of this Agreement and the benefits provided are specific to Executive and,
as such, any benefits and compensation that may or may not be provided to other Company executives are not relevant to this Agreement.

 

f.
Vacation. During Executive’s Employment, Executive shall be entitled to twenty-five (25) paid vacation days
per calendar year (prorated for partial years) in accordance with the Company’s vacation policies, as in effect from time to time.
Executive shall receive other leaves in accordance with applicable law and the Company’s policies for executive officers, as such
policies may exist from time to time, and subject to prior agreements between the parties.

 

g.
Taxes and Withholdings. All amounts payable to Executive under this section shall be subject to all required federal,
state, and local withholdings, payroll deductions, and taxes and requirements under applicable laws.

 

5.
Definitions. For purpose of this Agreement,

 

a.
“Affiliate” means, with respect to any Person, any Person that controls, is controlled by or is under common
control with such Person or an Affiliate of such Person.

 

b.
“Cause” means any of the following conduct by Executive:

 

i.
the failure to successfully pass the Company’s background screening, which may include, but is not limited to, criminal and financial
background investigations, and verification of prior employment, education, degrees, certifications, training, and other credentials;

 

ii.
the conviction or admission, including a plea of nolo contendre, of a felony, or the conviction or admission of any other act
or omission involving material dishonesty or fraud with respect to the Company or any of its Subsidiaries or Affiliates;

 

iii.
the failure to perform material duties of the position held by Executive, or any other material breach of this Agreement by Executive,
which breach remains uncured for a period of ten (10) days after the Company’s written notice to Executive describing such breach;

 

iv.
a material act of dishonesty, fraud, misappropriation, embezzlement, breach of trust, or intentional misconduct with respect to the Company
or any of its Subsidiaries or Affiliates;

 

v.
the illegal use or possession of drugs in or on the Company’s workplace or premises;

 

vi.
the excessive use of alcohol in or on the Company’s workplace or premises;

 

vii.
intentional and willful misconduct that may subject the Company to criminal or civil liability;

 

    	Page 3 of 22

     

    

 

viii.
breach of Executive’s fiduciary duty or duty of loyalty owed to the Company or any of its Subsidiaries or Affiliates;

 

ix.
material or repeated failure to comply with the Company’s policies
and procedures;

 

x.
failure to cooperate in any investigation by the Company or with any investigation,
inquiry, hearings, or similar proceedings by any governmental authority having jurisdiction over the Company or its Subsidiaries or Affiliates;

 

xi.
being found unsuitable for, or having been denied, a gaming license, or having such license revoked by a gaming regulatory authority
in any jurisdiction in which the Company or any of its subsidiaries or affiliates conducts operations;

 

xii.
willful or material misrepresentation to the Company or to Board relating to the business, assets or operations of the Company, or

 

xiii.
breach of any of the material terms of this Agreement.

 

c.
“Change-in-Control” shall mean and include any of the following occurrences:

 

i.
Any Person, including a group as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, becomes the beneficial
owner of stock of the Company with respect to which fifty percent (50%) or more of the total number of votes for the election of the
Board may be cast;

 

ii.
As a result of, or in connection with, any cash tender offer, exchange offer, merger or other business combination, sale of assets or
contested election, or combination of the foregoing, persons who were directors of the Company just prior to such event shall cease to
constitute a majority of the Board;

 

iii.
The consummation of a sale or other disposition of all or substantially all the assets of the Company; or

 

iv.
A tender offer or exchange offer is made and consummated for the ownership of securities of the Company representing fifty percent (50%)
or more of the combined voting power of the Company’s then outstanding voting securities.

 

A
transaction shall not constitute a Change-in-Control if its sole purpose is to change the jurisdiction of the Company’s incorporation
or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities
immediately before such transactions.

 

d.
“Claim” or “Claims” means any allegation, dispute, claim, causes of action, complaint,
grievance, charge, action, petition, or demand.

 

e.
“Disability” means the disability of Executive caused by any physical or mental injury, illness, or incapacity,
as a result of which Executive is unable to effectively perform the essential functions of Executive’s duties for a continuous
period of more than 90 days or for 120 days (whether or not continuous) in any 240-day period, as determined by an independent, legally
qualified medical doctor selected by the Company’s health or disability insurer.

 

f.
“Good Reason” means, without Executive’s written consent: (i) any material diminution in Executive’s
authorities, duties, titles, or responsibilities with the Company or successor company; (ii) any material reduction of Executive’s
benefits, unless such reduction is in connection with a general reduction of benefits across the Company or successor company; (iii)
any reduction in Executive’s compensation, including but not limited to a reduction in Executive’s potential Target Bonus,
unless such reduction is in connection with a general reduction of compensation across the Company or successor company; (iv) any change
in Executive’s direct reporting line to the CEO of the parent company or successor parent company; (v) relocation of Executive’s
Principal Place of Business outside of a 30 mile radius without the express written consent of Executive, or (vi) any failure to pay
timely and completely any Base Salary or Target Bonus owed to Executive for work performed for the benefit and on behalf of the Company.

 

    	Page 4 of 22

     

    

 

g.
“Person” means an individual, a partnership, a limited liability company, a corporation, an association, a
joint stock company, a trust, a joint venture, an unincorporated organization, investment fund, any other business entity and a governmental
entity, or any department, agency or political subdivision thereof.

 

h.
“Subsidiary” means with respect to any Person, any corporation, limited liability company, partnership, association,
or business entity of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to
the occurrence of any contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled,
directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a
limited liability company, partnership, association, or other business entity (other than a corporation), a majority of partnership or
other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries
of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest
in a limited liability company, partnership, association, or other business entity (other than a corporation) if such Person or Persons
shall be allocated a majority of limited liability company, partnership, association, or other business entity gains or losses or shall
be or control any managing director or general partner of such limited liability company, partnership, association, or other business
entity. For purposes hereof, references to a “Subsidiary” of any Person shall be given effect only at such times that such
Person has one or more Subsidiaries, and, unless otherwise indicated, the term “Subsidiary” refers to a Subsidiary of the
Company.

 

i.
“Termination Date” means:

 

i.
if Executive’s employment hereunder terminates on account of Executive’s death, the date of Executive’s death;

 

ii.
if Executive’s employment hereunder is terminated on account of Executive’s Disability, the date that it is determined that
Executive has a Disability;

 

iii.
if the Company terminates Executive’s employment hereunder for Cause, the date the written notice of termination is delivered to
Executive;

 

iv.
if the Company terminates Executive’s employment hereunder without Cause, the date specified in the written notice of termination
delivered to Executive; and

 

v.
if Executive terminates his employment hereunder with or without Good Reason, the date specified in Executive’s written notice
of termination delivered to the Company.

 

Notwithstanding
anything contained herein, the Termination Date shall not occur until the date on which Executive incurs a “separation from service”
within the meaning of Section 409A of the Internal Revenue Code.

 

6.
Indemnification. The Parties have executed an Indemnification Agreement, attached hereto Exhibit B and incorporated
by reference. The Company shall indemnify, defend, and hold harmless Executive from and against Claims, losses, damages, liabilities,
actions, judgments, court costs, and legal and other expenses pursuant to the terms of the Indemnification Agreement.

 

7.
Termination of Employment and Severance. Upon termination of Executive’s employment with the Company, for any reason,
Executive shall receive (i) all earned, but unpaid, Base Salary as of the Termination Date; (ii) all earned, but unpaid, Target Bonuses
as of the Termination Date; (iii) all earned and vested Equity Awards as of the Termination Date; (iv) accrued and earned, but unused,
vacation days as of the Termination Date; and (v) payment of any outstanding reimbursable business expenses submitted to the Company
in accordance with the Company’s policies and procedures (collectively, “Accrued Payments”; individually, an
“Accrued Payment”). The Company shall pay Executive the Accrued Payments pursuant to the timing requirements set forth
in applicable law.

 

    	Page 5 of 22

     

    

 

a.
Termination for Cause. The Company may, at any time and without notice, terminate Executive’s employment with the
Company for Cause. In the event the Company terminates Executive’s employment for Cause, the Company shall provide only Accrued
Payments to Executive; the Company shall not provide Executive any unearned Target Bonus or unvested Equity Awards.

 

b.
Voluntary Termination (Other Than for Good Reason). Executive may, at any time and without notice, voluntarily terminate
Executive’s employment with the Company without Good Reason. In the event Executive terminates Executive’s employment with
the Company on any basis other than for Good Reason, the Company shall provide only Accrued Payments to Executive; the Company shall
not provide Executive any unearned Target Bonus or unvested Equity Awards.

 

c.
Termination for Good Reason. Executive may voluntarily terminate Executive’s employment with the Company with Good
Reason. If Executive provides written notice to the CEO within 180 days after the event or condition constituting Good Reason arises,
and the Company fails to remedy the event or condition (if capable of curing) within thirty (30) days after the written notice provided
to the CEO, the Company shall provide to Executive: (i) Accrued Payments; (ii) a cash severance payment in an amount equal to one (1)
times the sum of Executive’s then-current Base Salary and Target Bonus, payable in a lump sum within ten (10) calendar days of
the Termination Date, (iii) a pro rata bonus payment in an amount equal to the Target Bonus for the year in which the Termination Date
occurs multiplied by a fraction the numerator of which is the number of days in the applicable
year through the Termination Date and the denominator of which is 365, with such amount payable in a lump sum on the date in which the
Company pays bonuses to other employees for the applicable year (the “Pro Rata Bonus”); (iv) notwithstanding
anything to the contrary in this Agreement, Award Agreement, or elsewhere, Executive’s unvested Equity Awards will accelerate and
become vested, non-forfeitable, and exercisable on a pro rata basis as of the Termination Date, regardless of any limitation with respect
to time, performance, vesting, or other restrictions, based on the portion of the vesting period of the applicable Equity Award during
which Executive was an active employee of the Company (the “Pro Rata Acceleration”); and (v) on a monthly basis, for
a period of twelve (12) months, the Company’s monthly share of premiums required to continue Executive’s and Executive’s
dependents group health insurance benefits (medical, dental, and vision) after the Termination Date under the applicable provisions of
the Consolidated Omnibus Budget Reconciliation Act (“COBRA”); provided that the Company shall cease paying such COBRA
premiums on the day Executive begins employment with another company, entity, or Person following the Termination Date and is eligible
to receive similar benefits.

 

d.
Termination Without Cause; Termination Due to Death or Disability. The Company may, at any time and without notice, terminate
Executive’s employment with the Company without Cause. In the event the Company terminates Executive’s employment without
Cause, the Company shall provide to Executive: (i) Accrued Payments; (ii) a cash severance payment in an amount equal to one (1) times
the sum of Executive’s then-current Base Salary, payable in a lump sum within ten (10) calendar days of the Termination Date, (iii)
the Pro Rata Bonus; (iv) the Pro Rata Acceleration; and (v) on a monthly basis, for a period of twelve (12) months, the Company’s
monthly share of premiums required to continue Executive’s and Executive’s dependents group health insurance benefits (medical,
dental, and vision) after the Termination Date under the applicable provisions of COBRA; provided that the Company shall cease paying
such COBRA premiums on the day Executive begins employment with another company, entity, or Person following the Termination Date and
is eligible to receive similar benefits.

 

    	Page 6 of 22

     

    

 

e.
Conditions of Payments. Excluding Accrued Payments, all payments set forth in this section that are not otherwise required
by law shall be payable so long as:

 

i.
Executive complies with this Agreement, including, but not limited to, Section 9 through Section 14; and

 

ii.
Within sixty (60) days of the Termination Date, Executive (or Executive’s beneficiary or estate) delivers to the Company and does
not revoke (under the terms of applicable law) a general release of all of Executive’s Claims against the Company, the Company’s
Affiliates, and the Company’s Subsidiaries substantially in the form attached hereto as Exhibit C; provided that, if necessary,
such general release may be updated and revised to comply with applicable law to achieve its intent. The Company is not obligated to
make any payments to Executive other than Accrued Payments in the event of Executive’s failure to execute and return such release
without revocation; provided that, the Company must first notify Executive or Executive’s estate of the failure to deliver such
general release and provide to Executive or Executive’s estate ten (10) business days to cure such failure.

 

f.
[Intentionally Omitted].

 

g.
Tax Treatment and Internal Revenue Service Code 409A.

 

i.
To the extent applicable, this Agreement shall be interpreted in accordance with Section 409A of the Code and Department of Treasury
regulations and other interpretive guidance issued thereunder (together, “Section 409A”). Notwithstanding any provision
of this Agreement to the contrary, if the Company determines that any compensation or benefits payable under this Agreement may be subject
to Section 409A, the Company shall work in good faith with Executive to adopt such amendments to this Agreement or adopt other policies
and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Company determines
are necessary or appropriate to avoid the imposition of taxes under Section 409A, including without limitation, actions intended to (i)
exempt the compensation and benefits payable under this Agreement from Section 409A, and/or (ii) comply with the requirements of Section
409A; provided, however, that this section shall not create an obligation on the part of the Company to adopt any such
amendment, policy or procedure or take any such other action, nor shall the Company have any liability for failing to do so.

 

ii.
Any right to a series of installment payments pursuant to this Agreement is to be treated as a right to a series of separate payments.
To the extent permitted under Section 409A, any separate payment or benefit under this Agreement or otherwise shall not be deemed “nonqualified
deferred compensation” subject to Section 409A to the extent provided in the exceptions in Treasury Regulation Section 1.409A-1(b)(4),
Section 1.409A-1(b)(9) or any other applicable exception or provision of Section 409A. All payments of nonqualified deferred compensation
subject to Section 409A to be made upon a termination of employment under this Agreement may only be made upon Executive’s “separation
from service” from the Company (within the meaning of Section 409A, a “Separation from Service”).

 

iii.
Notwithstanding anything to the contrary in this Agreement, no compensation or benefits, including without limitation any severance payments
or benefits payable under this section, shall be paid to Executive during the six 6-month period following Executive’s Separation
from Service if the Company determines that paying such amounts at the time or times indicated in this Agreement would be a prohibited
distribution under Section 409A(a)(2)(B)(i) of the Code. If the payment of any such amounts is delayed as a result of the previous sentence,
then on the first day of the seventh month following the date of Separation from Service, such earlier date upon which such amount can
be paid under Section 409A without resulting in a prohibited distribution, including as a result of Executive’s death), the Company
shall pay Executive a lump-sum amount equal to the cumulative amount that would have otherwise been payable to Executive during such
period.

 

iv.
To the extent that any payments or reimbursements provided to Executive under this Agreement are deemed to constitute compensation to
Executive to which Treasury Regulation Section 1.409A-3(i)(1)(iv) would apply, such amounts shall be paid or reimbursed reasonably promptly,
but not later than December 31 of the year following the year in which the expense was incurred. The amount of any such payments eligible
for reimbursement in one year shall not affect the payments or expenses that are eligible for payment or reimbursement in any other taxable
year, and Executive’s right to such payments or reimbursement of any such expenses shall not be subject to liquidation or exchange
for any other benefit

 

    	Page 7 of 22

     

    

 

h.
Internal Revenue Service Code 280G. In the event that it is determined that any payment or distribution of any type to
or for Executive’s benefit made by the Company, by any of its affiliates, by any person who acquires ownership or effective control
or ownership of a substantial portion of the Company’s assets (within the meaning of Section 280G of the Code) or by any affiliate
of such person, whether paid or payable or distributed or distributable pursuant to the terms of an employment agreement or otherwise,
would be subject to the excise tax imposed by Section 4999 of the Code or any interest or penalties with respect to such excise tax (such
excise tax, together with any such interest or penalties, are collectively referred to as the “Excise Tax”), then
such payments or distributions or benefits shall be payable either: (i) in full; or (ii) as to such lesser amount which would result
in no portion of such payments or distributions or benefits being subject to the Excise Tax. Executive shall receive the greater, on
an after-tax basis, of (i) or (ii) above, provided however that to the extent applicable, Executive may elect to subject the payments
that are in excess of the permissible maximum payment amount specified under Code section 280G(b)(2)(A)(ii) to a stockholder vote as
provided for under Code section 280G(b)(5).

 

i.
Final, Binding Determination. Unless Executive and the Company agree otherwise in writing, any determination required under
this section shall be made in writing by an independent accountant, with expertise in executive compensation and tax, selected by the
Company (the “Accountant”) whose determination shall be based on prevailing accounting principles and shall be conclusive
and binding. Accountant’s determination shall be provided to the Company and Executive and include all analysis and information
necessary for the parties to fully understand the basis of such determination. Upon Executive’s request, Company shall make Accountant
available to Executive (and Executive’s personal advisors if Executive so chooses) from time to time to provide an opportunity
to make reasonable inquiries about the methodology used in arriving at the determination or Executive’s tax liability. Executive
and the Company shall furnish the Accountant such documentation and documents as the Accountant may reasonably request in order to make
a determination. The Company shall bear all costs and fees that the Accountant may incur in connection with this Section.

 

j.
No Impact on At-Will Relationship. As set forth in Section 1, Executive’s employment with the Company is at-will.
Accordingly, either Party may terminate Executive’s employment with or without Cause, and with or without notice. Nothing in this
section shall alter, modify, impact, or change either Party’s right to terminate Executive’s employment with the Company,
with or without cause, and with or without notice.

 

8.
Change-in-Control Payments and Benefits. Not in limitation of the forgoing, upon a Change-in-Control, Executive shall be
entitled to the additional payments and equity treatment set forth in this section incremental to any other compensation due to Executive
under this Agreement.

 

a.
Equity Acceleration. Notwithstanding anything to the contrary in this Agreement, Award Agreement, or otherwise, if Executive’s
employment is terminated by the Company without Cause or by Executive for Good Reason within three (3) months before or two (2) years
after a Change-in-Control occurs, all of Executive’s Equity Awards shall accelerate and become fully vested, non-forfeitable, and
exercisable, regardless of any limitation with respect to time, performance, vesting, or other restrictions.

 

b.
Elevated Cash Severance and Benefits. If Executive’s employment is terminated by the Company without Cause or by
Executive for Good Reason within three (3) months before or two (2) years after a Change-in-Control occurs, then the Company shall (i)
in lieu of any amounts payable under Section 7(c) or 7(d), provide to Executive a cash severance payment in an amount equal to one and
one-half (1.5) times the sum of Executive’s then-current Base Salary and Target Bonus, payable in a lump sum within ten (10) calendar
days of the Termination Date, (ii) the Pro Rata Bonus; and (iii) on a monthly basis, for a period of eighteen (18) months, pay the Company’s
monthly share of premiums required to continue Executive’s and Executive’s dependents group health insurance benefits (medical,
dental, and vision) after the Termination Date under the applicable provisions of COBRA; provided that the Company shall cease paying
such COBRA premiums on the day Executive begins employment with another company, entity, or Person following the Termination Date and
is eligible to receive similar benefits.

 

    	Page 8 of 22

     

    

 

9.
Non-Disclosure and Non-Use of Confidentiality, Proprietary, and Trade Secret Information.

 

a.
Protection Against Disclosure. Executive acknowledges that, during Executive’s employment with the Company, Executive
will gain knowledge of and access to certain Confidential Information (as defined below in Section 9(e)). Executive agrees to
undertake a fiduciary obligation to protect against the disclosure and use of any Confidential Information. Both during and after Executive’s
Employment, Executive shall not disclose, communicate, divulge, or allow another Person to use to their personal, competitive, or economic
advantage any Confidential Information, except where Executive has received prior written consent from the CEO or as otherwise required
by law or by judicial or administrative process or order, and in that case only after complying with Section 9(b) below.

 

b.
Notifying the Company. If a Person not a Party to this Agreement requests or demands that Executive disclose Confidential
Information or produce documents containing Confidential Information, Executive will, to the extent permitted by law, immediately notify
the CEO and will provide the Company a reasonable opportunity to respond to such request or demand before Executive responds to the request
or demand.

 

c.
Defend Trade Secrets Act Notice. Notwithstanding the foregoing nondisclosure obligations, pursuant to 18 U.S.C. §
1833(b), Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a
trade secret that is made: (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to
an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (ii) in a complaint or other document
filed in a lawsuit or other proceeding, if such filing is made under seal.

 

d.
Disclosure to Government Agencies. Executive understands and acknowledges that nothing contained in this Agreement limits
Executive’s ability to file a charge or complaint with the U.S. Equal Employment Opportunity Commission, the National Labor Relations
Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, or any other federal, state, or local
governmental agency or commission, including state or tribal gaming regulators (individually, “Government Agency”;
collectively, “Government Agencies”). Executive further understands and acknowledges that this Agreement does not
limit Executive’s ability to communicate with any Government Agencies or to otherwise participate in any investigation or proceeding
that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.

 

e.
Definition of Confidential Information. As used herein, “Confidential Information” means any Company
confidential, proprietary, or trade secrets information, including, but not limited to, technical data, know-how, research, product plans
and developments, prototypes, products, services, client lists, prospective clients list, client or potential client contact information,
proposals, client purchasing practices, prices and pricing methodology, cost information, terms and conditions of business relationships
with clients, client research and other needs, markets, software, developments, inventions, processes, formulas, technology, designs,
drawings, engineering, distribution and sales methods and systems, sales and profit figures, financial information, business information,
operation information, plans, personnel information, as well as reports and other business information that Executive learns of, obtains,
or that is disclosed to Executive during Executive’s Employment.

 

    	Page 9 of 22

     

    

 

f.
The restrictions provided for in this section shall not be construed to prohibit the use of general knowledge and experience customarily
relied upon in Executive’s trade or profession that is not specific to the particular business matters of the Company (such as
its technology or customers), nor shall it be construed to be a form of covenant not to compete (such a construction would be contrary
to the intent of the parties). Notwithstanding the foregoing, the unauthorized disclosure of a particular item of Confidential Information
to a competitor will qualify as prohibited misappropriation of the Confidential Information. Executive acknowledges and agrees that the
Confidential Information is the property of Company and a special and unique asset of the Company. The Confidential Information derives
independent economic value, actual or potential, from not being generally known by the public or by other persons or entities who can
obtain economic value from its use or disclosure, and thus shall be protected.

 

g.
Return of Company Property. Upon any termination of this Agreement, termination of Executive’s employment, or any
request by the Company, Executive shall immediately return all Company property, documents, files, records, stored data, emails, pictures,
videos, laptops, computers, phones, equipment, and Confidential Information to Company.

 

10.
Inventions and Assignments.

 

a.
Assignment to the Company. Any and all products, writings, inventions, improvements, processes, formulas, procedures, and
techniques which Executive may make, conceive, discover, or develop, either solely or jointly with any other person, at any time when
Executive is an employee of the Company, whether or not during working hours and whether or not at the request or upon the suggestion
of the Company, which relate to or are useful in connection with any business now or hereafter carried on or contemplated by the Company,
including developments or expansions of its present fields of operations, shall be the sole and exclusive property of the Company. Executive
shall make full disclosure to the Company of all such products, writings, inventions, improvements, processes, procedures, formula, and
techniques and shall do everything necessary or desirable to vest the absolute title thereto in the Company. Executive shall write and
prepare all specifications, formulas, and procedures regarding such products, inventions, improvements, processes, procedures, and techniques
and otherwise aid and assist the Company so that the Company can prepare and present applications for copyright or patent letters therefore
and can secure such copyright or patent letters wherever possible, as well as reissues, renewals, and extensions thereof, and can obtain
the records title to such copyright or patents so that the Company shall be the sole and absolute owner thereof in all countries in which
it may desire to have copyright or patent protection. Executive shall not be entitled to any additional or special compensation or reimbursement
regarding any and all such writings, inventions, improvements, formulas, processes, procedures and techniques.

 

b.
California Labor Code Section 2872 Notice. Notwithstanding the foregoing rights and obligations, and pursuant to California
Labor Code section 2872, a Company invention shall not include inventions which qualifies fully under the provisions of California Labor
Code section 2870 (a copy of which is attached as Exhibit D), including any idea or invention which is developed entirely on Executive’s
own time without using Company’s equipment, supplies, facilities, or trade secrets, and which is not related to the Company’s
business (either actual or demonstrably anticipated), and which does not result from work performed for the Company.

 

11.
Additional Restrictive Covenants. Executive understands that the nature of Executive’s position gives Executive access
to and knowledge of Confidential Information and places him or her in a position of trust and confidence with the Company. Executive
further understands and acknowledges that the Company’s ability to reserve these for the exclusive knowledge and use of the Company
is of great competitive importance and commercial value to the Company, and that improper use or disclosure by Executive is likely to
result in unfair or unlawful competitive activity. Executive acknowledges that the Company has expended, and will continue to expend,
substantial time, money and effort in developing its Confidential Information; Executive may in the course of Executive’s employment
be personally entrusted with and exposed to the Company’s Confidential Information and may have access to the Company’s customers;
and the Company would suffer great loss and irreparable harm if Executive were to enter into competition with the Company. Therefore,
accordingly, Executive acknowledges and agrees to the restrictive covenants set forth in this section.

 

    	Page 10 of 22

     

    

 

a.
Non-Competition. Executive agrees that during Executive’s employment with the Company, and for one (1) year
following the Termination Date (the “Covenant Period”), Executive will not directly or through others, whether as
an owner, director, officer, manager, consultant or employee: (i) provide services for the benefit of any Restricted Business (as defined
below) within the Territory (as defined below) that are the same or similar in function or purpose to those Executive provided to the
Company during the last year of Executive’s employment with the Company or such shorter period of time as Executive was employed
by the Company (“Look Back Period”); or, (ii) take on any other responsibilities for a Restricted Business that would
involve the probable use or disclosure of Confidential Information or the conversion of Covered Customers (as defined below) to the benefit
of a Competing Business or detriment of the Company. For purposes of this Agreement, “Restricted Business” means those
entities or persons primarily engaged in the business of developing, marketing, selling, licensing, and supplying online gaming technology
to gaming businesses (business to business) in which the Company engages or in which the Company has an actual intention, as evidenced
by the Company’s written business plans to engage, in any country in which the Company does business as of the Termination Date.
Because Executive is employed by the Company in a senior management position, Executive is presumed to have participated in the Company’s
business and/or had Confidential Information about the Company’s business throughout the United States (including state and state-equivalents
and county and county-equivalents therein), and therefore “Territory” means the United States. For the avoidance of
doubt, gaming companies that do not conduct business primarily online, and provide products primarily to other businesses, shall not
be considered a Restricted Business. Executive agrees that the restrictions on competition, as to time, geographic area, and scope of
activity, required by this section are reasonable, do not impose a greater restraint that necessary to protect the goodwill and business
interests of the Company, and are not unduly burdensome to Executive.

 

b.
Non-Compete Consideration; Waiver. In exchange for Executive’s non-compete restriction during the Covenant Period,
the Company shall continue to pay Executive’s Base Salary during the Covenant Period (“Garden Leave Compensation”).
The Garden Leave Compensation is specifically intended to compensate Executive for the non-compete restriction, and for the avoidance
of doubt, the Garden Leave Compensation shall be cumulative in nature and shall not be reduced or offset by any other payments owed to
Executive under this Agreement. Notwithstanding the forgoing, the Company may, upon sixty (60) days prior written notice, in its sole
discretion and at any time, elect to waive, in writing, the non-compete restrictions imposed on Executive for all or any portion of the
Covenant Period. The Company shall not pay Garden Leave Compensation to Executive for any portion of the Covenant Period where it waived
the non-compete restriction, nor shall the Company pay Garden Leave Compensation after Executive begins employment with another company,
entity or Person, provided that, employment with a non-profit organization, in public service, or the education sector shall not disqualify
Executive from collecting Garden Leave Compensation. Executive shall promptly notify the Company of any employment that may disqualify
Executive from receiving Garden Leave Compensation. Any waiver of the non-compete restriction shall be permanent, and the Company cannot
later seek to enforce the non-compete restriction on Executive after any waived period.

 

c.
Non-Solicitation. Executive agrees that during Executive’s employment with the Company, and for the Covenant Period,
Executive will not (i) solicit any employee of the Company that Executive gained knowledge of through Executive’s employment with
the Company (a “Covered Employee”) to leave the employment of the Company; or, (ii) assist with hiring or attempting
to hire any Covered Employee on behalf of a Restricted Business; or, (ii) solicit, or attempt to solicit a Covered Customer (defined
below) for the purpose of doing any business that would compete with the Company’s business; or, (iv) knowingly engage in any conduct
that is intended to cause, or could reasonably be expected to cause the Covered Customer (as defined below) to stop or reduce doing business
with the Company, or that would involve diverting business opportunities away from the Company. “Covered Customer”
means a customer or potential customer that Executive had material business-related contact or dealings with or access to Confidential
Information about during the Look Back Period.

 

    	Page 11 of 22

     

    

 

d.
If California law is deemed to govern this Section 11, then Paragraphs 11(a), 11(b)(i), and 11(b)(ii) shall not
apply. Paragraphs 11(b)(iii) and 11(b)(iv) only shall apply to the extent the solicitation involves the misappropriation of the Company’s
trade secret information, such as its protected customer information, as defined by applicable law.

 

e.
If Nevada law is deemed to govern this Section 11, then Paragraphs 11(b)(iii) and 11(b)(iv) shall not apply to former
customers or clients of the Company, if (i) Executive did not solicit the former customer or client; (ii) the customer or client voluntarily
chose to leave and seek services from Executive; and (iii) Executive is otherwise complying with the limitations in this Agreement as
to time and scope of activity to be restrained.

 

12.
Cooperation with the Company. The Parties agree that certain matters in which Executive will be involved during Executive’s
Employment may necessitate Executive’s cooperation in the future. Accordingly, following the termination of Executive’s employment
for any reason, Executive shall cooperate with the Company regarding any Claim relating to any lawsuit, action, investigation, or audit
that (a) is brought by or against the Company and (b) is directly or indirectly related to Executive’s employment with the Company.
Company shall reimburse Executive within 14 calendar days for any reasonable expenses or fees incurred by Executive during such cooperation
so long as Executive provides receipts or other reasonable evidence of such expenses to the Company.

 

13.
No Cooperation Against the Company. Executive agrees that Executive will not knowingly encourage, counsel, or assist any
attorneys or their clients in the presentation or prosecution of any Claim by any third party or Person against the Company and Affiliates,
unless under a subpoena or other court order to do so, and except as otherwise provided in Section 9(c) and 9(d). Executive
agrees both to immediately notify Company (pursuant to Section 17 below) upon receipt of any such subpoena or court order relating
to the Company and Affiliates, and to immediately furnish a copy of such subpoena or other court order.

 

14.
Non-Disparagement.

 

a.
Both during and after Executive’s employment with the Company, Executive shall refrain from any disparagement, defamation, libel,
or slander of any of the Company and Affiliates. Executive further agrees to refrain from any tortious interference with the contracts
and relationships of any of Company and Affiliates. This Section 14(a) does not prohibit Executive from disclosing illegal acts
that occurred at, or is related to, the Company’s workplace.

 

b.
Both during and after Executive’s employment with the Company, the Board, President and Executive Vice Presidents (collectively,
the “Company Representatives”) shall refrain from any disparagement, defamation, libel, or slander of any of Executive.
Nothing in this Section 14(b) shall prohibit the Company Representatives from discussing with third parties, including, but not
limited to, reference requests from Executive’s future employers, regarding: (i) Executive’s date of employment; (ii) the
status of Executive’s employment with the Company, if any at the time. Furthermore, nothing in this Section 14(b) shall
prohibit the Company Representatives from engaging in internal discussions within the Company regarding Executive’s performance
or the satisfaction or execution of Executive’s duties, responsibility, obligations, or authority.

 

15.
Equitable Remedies. Executive acknowledges and agrees that the Company and Affiliates could be irreparably damaged in the
event that any provision of this Agreement were breached and that money damages could be an inadequate remedy for any such nonperformance
or breach. Executive agrees that, to the extent permissible under applicable law, the Company shall be entitled, in addition to all other
rights and remedies existing in their favor, to seek injunctive or other equitable relief (including a temporary restraining order, a
preliminary injunction, and a final injunction) against Executive to prevent any actual or threatened breach of any of such provisions
and to enforce such provisions specifically in any court of the United States or any state having jurisdiction, without the necessity
of posting a bond or other security or of proving actual damages.

 

    	Page 12 of 22

     

    

 

16.
Arbitration. The Parties agree that:

 

a.
Scope. Except for Excluded Claims (as defined below in Section 16(g)), any and all Claims arising out of the terms
of this Agreement, Executive’s employment with the Company, the separation of Executive’s Employment with the Company, or
Executive’s relationship with the Company and Affiliates shall be subject to arbitration in Orange County, California before JAMS,
pursuant to the then-existing version of the JAMS Employment Arbitration Rules & Procedures (“JAMS Rules”). The
Parties can obtain a copy of the JAMS Rules (i) on the JAMS’ website (https://www.jamsadr.com/rules-employment); (ii) by
calling JAMS directly at (800) 352-5267; or (iii) from the Company’s Human Resources Department. The JAMS Rules are incorporated
herein by reference. Additionally, pursuant to this Section 16, the Parties agree to arbitrate any and all Claims for violation
of any federal, state, local or municipal statute or ordinance, including, but not limited to, Title VII of the Civil Rights Act of 1964;
the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair
Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection
Act; the federal Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; the California Adjustment and Retraining
Notification Act; the California Fair Employment and Housing Act; the California Family Rights Act; the California Labor Code; and the
California Business and Professions Code.

 

b.
Arbitrability. The arbitrator, not a court, will determine issues of arbitrability or waiver of arbitrability. The Parties
waive any right to have a court determine issues of arbitrability.

 

c.
Arbitrator’s Authority. The arbitrator may grant injunctions and other relief in Claims subject to arbitration pursuant
to this Agreement. The arbitrator shall administer and conduct any arbitration in accordance with California law, including the California
Code of Civil Procedure, and the arbitrator shall apply substantive and procedural California law to any Claim, without references to
conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules are in irreconcilable conflict with California law,
California law shall take precedence over the JAMS Rules.

 

d.
Final and Binding Arbitration. The decision of the arbitrator shall be final, conclusive, and binding on the Parties. The
Parties agree that that the prevailing party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction
to enforce the arbitration award.

 

e.
Injunctive Relief. The parties hereby agree to waive their right to have any Claim between them resolved in a court of
law by a judge or jury. Notwithstanding the foregoing, this Section 16(e) will not prevent either Party from seeking injunctive
relief (or any other provisional remedy) from any court having jurisdiction over the Parties and the subject matter of their Claim relating
to this Agreement and the agreements incorporated herein by reference.

 

f.
Class Action Waiver. Except for Excluded Claims (as defined below in Section 16(g)), the Parties intend and agree
that (i) class action and representative action procedures are hereby waived and shall not be asserted, nor will they apply, in any arbitration
pursuant to this Agreement; (ii) each Party will not assert class action or representative action Claims against the other Party in arbitration
or otherwise; and (iii) the Parties shall only submit their own, individual Claims in arbitration and will not seek to represent the
interests of any other person. To the extent the Parties’ Claims involve both timely filed Excluded Claims and Claims subject to
arbitration under this Agreement, the Parties agree to bifurcate Excluded Claims from Claims subject to arbitration, and stay the Excluded
Claims for the duration of the arbitration proceedings.

 

    	Page 13 of 22

     

    

 

g.
Excluded Claims. “Excluded Claims” are causes of action or claims: (i) under Section 7 of the National Labor
Relations Act, (ii) for representative actions under the California’s Private Attorneys’ General Act (“PAGA”),
(ii) under the California Workers’ Compensation Act, (iv) for unemployment compensation benefits; (v) for benefits under a plan
that is governed by the Employee Retirement Income Security Act of 1974, (vii) occurring after a Change in Control, and (viii) expressly
prohibited from mandatory arbitration under applicable law. To the extent permitted by law, individual Claims under PAGA or Claims under
California Labor Code section 558(a) are not Excluded Claims, and thereby are subject to arbitration pursuant to this Agreement.

 

h.
Arbitration Costs and Fees. With respect to costs associated with the arbitration under this Section 16, Executive
shall only pay the JAMS filing or administrative fee up to the equivalent amount of the initial filing Executive would have paid to commence
an action in the California Superior Court, County of Orange. The Company will pay any other JAMS administrative fees, arbitrator’s
fees, and any additional fees unique to arbitration.

 

i.
Attorneys’ Fees for Motion to Compel Arbitration. A Party who is forced to file a motion or petition to compel arbitration
of a dispute arising under this Agreement may recover attorneys’ fees incurred in making the successful motion or petition.

 

j.
Operative Arbitration Agreement. Should any part of this Section 16 conflict with any other arbitration agreement
between the Parties, whether written, oral, or implied, the Parties agree that this Section 16 in this Agreement shall govern.

 

17.
Method of Providing Notice. Notices and all other communications provided for in this Agreement shall be in writing and
shall be delivered (a) personally or sent by registered or certified mail, return receipt requested, or by overnight carrier to the Parties
at the addresses set forth below or (b) by email to the email addresses set forth below:

 

If
to the Company: GAN Limited, 400 Spectrum Center Dr. Suite 1900, Irvine, CA 92618; Attention: Chief Legal Counsel (legal@gan.com);
with a copy to Human Resources (hr@gan.com).

 

If
to Executive: Michael B. Arouh,at the email address provided to the Company by Executive.

 

18.
Authority. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind
Company and all who may claim through them to the terms and conditions of this Agreement. Executive represents and warrants that Executive
has the capacity to act on Executive’s own behalf and on behalf of all who might claim through Executive to bind them to the terms
and conditions of this Agreement.

 

19.
No Representations. Executive represents that Executive has had an opportunity to consult with an attorney and has carefully read
and understands the scope and effect of the provisions of this Agreement. Executive has not relied upon any representations or statements
made by the Company that are not specifically set forth in this Agreement.

 

20.
Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof
becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall
continue in full force and effect without said provision or portion of provision.

 

21.
Fees and Costs. In the event that either Party brings an action to enforce or affect its rights under this Agreement, the prevailing
Party shall be entitled to recover its costs and expenses, including the costs of mediation, litigation, court fees, and reasonable attorneys’
fees incurred in connection with such an action (“Fees and Costs”). Specifically, unless otherwise prohibited by applicable
law, an arbitrator, court, governmental agency, or other judicial tribunal shall (i) award Fees and Costs to the prevailing party of
an arbitration under this Agreement and (ii) award Fees and Costs to the prevailing party in the event any legal action or arbitration
is commenced of any kind or character to enforce the provisions of this Agreement or to obtain damages for a breach thereof.

 

    	Page 14 of 22

     

    

 

22.
Mutual Drafting. Each Party has participated, or had the right to participate, in the drafting, negotiation, and preparation of
this Agreement. The Parties expressly waive any Claim, rule of law, contention, or argument that would require ambiguities in this Agreement
to be interpreted or construed against the Party that drafted the Agreement.

 

23.
Complete Integration; Entire Agreement. This Agreement (including Exhibits A, B, C, and D attached hereto) represents the entire
agreement and understanding between Company and Executive concerning the subject matter of this Agreement and Executive’s employment
with the Company. Except as subsequently modified pursuant to Section 24, this Agreement (including Exhibits A, B, C, and D attached
hereto) supersedes and replaces all prior agreements, offer letters, promises, representations, and understandings concerning the subject
matter of this Agreement and Executive’s employment with Company, including, but not limited to, the Prior Agreement. No extrinsic
evidence whatsoever may be introduced in any judicial proceedings or arbitration involving the parties’ intent in this Agreement.

 

24.
No Oral Modification. This Agreement shall only be amended in a writing signed by both Executive and the Company.

 

25.
Governing Law. This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions.
For any claim or action not covered in or subject to Section 16, Executive consents to personal and exclusive jurisdiction and
venue in the courts within Orange County, California or within the county surrounding Executive’s Principal Place of Business.

 

26.
Section Headings. Section headings used in this Agreement are for convenience of reference only and shall not affect the meaning
of any provision of this Agreement.

 

27.
Counterparts. This Agreement may be executed in counterparts, each of which shall have the same force and effect as an original
and shall constitute an effective, binding agreement on the part of each of the undersigned. The Parties also understand and agree that
a facsimile, electronic signature, or digital signature shall be deemed an original signature for purposes of this Agreement.

 

28.
Effective Date. This Agreement shall take effect upon the date in the preamble to the Agreement.

 

29.
Voluntary Execution of Agreement. Executive understands and agrees that they have executed this Agreement voluntarily, without
any duress or undue influence on the part or behalf of Company or any third party. Executive acknowledges that:

 

a.
Executive has read this entire Agreement;

 

b.
Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Executive’s
own choice or has elected not to retain legal counsel;

 

c.
Executive understands the terms and consequences of this Agreement; and

 

d.
Executive is fully aware of the legal and binding effect of this Agreement.

 

[End
of Executive Employment Agreement – Signature Page Follows]

 

    	Page 15 of 22

     

    

 

IN
WITNESS WHEREOF, the parties have duly executed this Executive Employment Agreement as of the date first above written.

 

	 	MICHAEL
    B. AROUH, an individual
	 	 	 
	 	By:	/s/
Michael B. Arouh
	 	Print
    Name:	Michael
    B. Arouh
	 	 	 
	 	GAN
    Nevada, Inc.
	 	 	 
	 	By:	/s/
    Dermot S. Smurfit
	 	Print
    Name:	Dermot
    Smurfit
	 	Print
    Title:	CEO

 

    	Page 16 of 22

     

    

  

EXHIBIT
A

 

[GAN
2020 Equity Incentive Plan]

 

    	Page 17 of 22

     

    

  

EXHIBIT
B

 

[GAN
Indemnification Agreement]

 

    	Page 18 of 22

     

    

 

EXHIBIT
C

 

[Form
Separation and Release Agreement]

 

SEPARATION
AND RELEASE AGREEMENT

 

This
Separation and Release Agreement (“Release”) is between GAN Limited and its Affiliates (“Company”) and
[ ■ ] (“Employee”). Employee and Employer shall be referred to herein, collectively, as the “Parties”
or, individually, as a “Party.”

 

RECITALS

 

WHEREAS,
the Parties previously executed an employment agreement, which may have been amended or modified from time to time (“Employment
Agreement”);

 

WHEREAS,
Employee’s employment with the Company has terminated or will terminate, and as a result of such termination the parties are entering
into this Release;

 

NOW,
THEREFORE, in consideration of the mutual promises made herein, the adequacy and sufficiency of which are hereby acknowledged, the Parties
hereby agree as follows:

 

COVENANTS

 

	1.	Defined
    Terms. All capitalized terms used in this Release not otherwise defined herein shall have the respective meanings ascribed in
    the Employment Agreement.
	 	 
	2.	Payment
    of Salary and Receipt of All Benefits. Employee acknowledges that Company has paid or provided all salary, wages, bonuses, accrued
    vacation/paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable
    expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Employee through the
    date hereof (collectively, “Earned Wages and Payments”). Accordingly, the Parties recognize, agree, and represent
    that California Labor Code section 206.5 is inapplicable. California Labor Code section 206.5(a) provides:

 

An
employer shall not require the execution of a release of a claim or right on account of wages due, or to become due, or made as an advance
on wages to be earned, unless payment of those wages has been made. A release required or executed in violation of the provisions of
this section shall be null and void as between the employer and the employee. Violation of this section by the employer is a misdemeanor.

 

The
payments from Company to Employee pursuant to the terms of this Agreement are not provided as a raise, bonus, or condition of employment;
and are not provided as a condition for Employee to receive the Earned Wages and Payments, which the Company has already paid Employee,
or any other amounts due under the Employment Agreement.

 

    	Page 19 of 22

     

    

 

	3.	Release
    of Claims.

 

	 	a.	By
    Employee. Employee hereby releases and forever discharges all claims against the Company, and each of its subsidiaries and the
    officers, directors, employees, attorneys and agents of the Company (“Company Releasees”) of whatever nature and kind,
    in law, equity or otherwise, known or unknown, choate or inchoate, asserted or unasserted, which Employee has had, may have had,
    or now has, or may have, arising out of or in connection with Employee’s employment with the Company or the termination of
    such employment, provided, however, that nothing contained herein is intended to nor shall constitute a release of the Company from
    any obligations it may have to Employee under the Employment Agreement, or any deferred compensation plan or arrangement in which
    Executive participates or any right of indemnification under any indemnification agreement or under the Company organizational documents,
    Bye-laws or the like as in effect on the execution date, or coverage under the Company’s director and officer insurance policy,
    nor shall it prevent Employee from exercising their rights, if any, under the Employment Agreement or under any stock option, restricted
    stock unit, restricted stock or similar agreement in accordance with their terms (collectively, “Employee Released Claims”).
    In addition, Employee Released Claims include without limitation, any and all claims for violation of any federal, state, or municipal
    statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation
    Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting
    Act; the Employee Polygraph Protection Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection
    Act; the Employee Retirement Income Security Act of 1974 (“ERISA”); the Worker Adjustment and Retraining Notification
    Act; the Family and Medical Leave Act; the Sarbanes-Oxley Act of 2002; the Occupational Safety and Health Act; the Uniform Services
    Employment and Reemployment Rights Act; the Rehabilitation Act of 1973; the Genetic Information Non-Discrimination Act; the Immigration
    Control and Reform Act; the Health Insurance Portability and Accountability Act of 1996; the California Family Rights Act; the California
    Labor Code; and the California Fair Employment and Housing Act. Employee agrees that they are not an “aggrieved employee”
    in any way for purposes of California’s Private Attorneys General Act (“PAGA”), California Labor Code §§
    2698 et seq., and therefore Employer is not liable for any penalties pursuant to PAGA for any conduct arising during Employee’s
    employment with the Company. Employee represents Employee has made no assignment or transfer of any right, claim, complaint, charge,
    duty, obligation, demand, cause of action, or other matter waived or released by this section. Should any claim be asserted in breach
    of the terms, covenants, and releases in this section, Employee agrees that this Release may be pled as a full and complete defense
    to such claim.
	 	 	 
	 	b.	By
    Company. The Company hereby releases and forever discharges all claims against Employee and Employee’s spouse, heirs, estate
    administrators and executors (collectively “Employee Releasees”) of whatever nature and kind, in law, equity or otherwise,
    known or unknown, choate or inchoate, asserted or unasserted, which the Company has had, may have had, or now has, or may have, arising
    out of or in connection with Employee’s employment with the Company or the termination of such employment; provided, however,
    that nothing contained herein is intended to nor shall constitute a release of Employee from any obligations they may have to the
    Company under the Employment Agreement in accordance with their terms (collectively “Company Released Claims”). Should
    any claim be asserted in breach of the terms, covenants, and releases in this section, the Company agrees that this Release may be
    pled as a full and complete defense to such claims.

 

	4.	Representations
    and Warranties.

 

	 	a.	By
    Employee. Employee represents and warrants that Employee is authorized by law and has the legal capacity to enter into this Release,
    that Employee has been advised to consult with an attorney of Employee’s choosing before signing this Release, and that Employee
    is not relying on any representation or warranty by the Company which is not expressly set out in this Release or in the Employment
    Agreement. Employee was given at least twenty-one (21) days to consider the terms of this Agreement and consult with an attorney
    of Employee’s choice, although Employee may sign this Agreement sooner if desired. Employee understands that Employee has seven
    (7) days after signing this Agreement (the “Revocation Period”) to revoke this Release by delivering notice of
    revocation to the Company before the end of this seven-day period; and Employee understands that this Release does not apply to rights
    and claims that may arise after the date on which Employee executes this Agreement. Employee acknowledges that Employee has been
    advised to consult with legal counsel and is familiar with the provisions of California Civil Code section 1542, a statute that otherwise
    prohibits the release of unknown Claims, which provides as follows:

 

A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR
AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE
DEBTOR OR THE RELEASED PARTY.

 

    	Page 20 of 22

     

    

 

Being
aware of said code section, Employee agrees to expressly waive any rights Employee may have thereunder, as well as under any other statute
or common law principles of similar effect.

 

	 	b.	By
    Company. The Company represents and warrants that the Company is authorized by law and has the legal capacity to enter into this
    Release. The person who executed this Release on the Company’s behalf has been duly authorized to execute this Release and
    to bind the Company to its terms and conditions, and the Company is not relying on any representation or warranty by Employee, which
    is not expressly set out in this Release or in the Employment Agreement.

 

	5.	Costs
    of Agreement. The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with
    the preparation of this Release.
	 	 
	6.	Arbitration.
    The Parties agree that the arbitration clause in the Employment Agreement shall govern any disputes under this Release.
	 	 
	7.	No
    Representations. Employee represents that Employee has had an opportunity to consult with an attorney and has carefully read
    and understands the scope and effect of the provisions of this Release. Employee has not relied upon any representations or statements
    made by the Company that are not specifically set forth in this Release.
	 	 
	8.	Severability.
    In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is
    declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Release shall continue in
    full force and effect without said provision or portion of provision.
	 	 
	9.	Entire
    Agreement. This Release represents the entire agreement and understanding between the Parties concerning the subject matter herein
    and Employee’s employment with and separation from the Company and the events leading thereto and associated therewith.
	 	 
	10.	No
    Oral Modification. This Agreement shall only be amended in a writing signed by both Employee and the Company.
	 	 
	11.	Governing
    Law. This Agreement shall be governed by the laws that govern Employee’s Employment Agreement, without regard for choice-of-law
    provisions.
	 	 
	12.	Effective
    Date. Employee understands that this Release shall be null and void if Employee does not execute the Release within twenty-two
    days (22) days from the date this Release is provided to Employee. This Agreement will become effective on the eighth (8th)
    calendar day after a copy signed by Employee is tendered to the Company (the “Effective Date”), so long as Employee has
    not revoked the Release.

 

AGREED
AND ACCEPTED:

 

	Employee
    Name, an individual

    

    

    
	 	GAN
    Limited, and Affiliates

    

		 	 
	 	 	 
	Print
    Name:	 	Print
    Name/Title:

 

    	Page 21 of 22

     

    

  

EXHIBIT
D

 

[California
Labor Code Section 2872 Notice]

 

WRITTEN
NOTIFICATION TO EMPLOYEE

 

In
accordance with California Labor Code section 2872, you are hereby notified that your Amended Employment Agreement does not require you
to assign to GAN Nevada, Inc. or its Affiliates (the “Company”) any Company intellectual property for which no equipment,
supplies, facility, or trade secret information of the Company was used and that was developed entirely on your own time, and does not
relate to the business of the Company or to the Company’s actual or demonstrably anticipated research or development, or does not
result from any work performed by you for the Company.

 

Following
is the text of California Labor Code section 2870:

 

	 	a.	Any
    provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in
    an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without
    using the employer’s equipment, supplies, facilities, or trade secret information, except for those inventions that either:

 

	 	(1)	Relate
    at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated
    research or development of the employer; or
	 	 	 
	 	(2)	Result
    from any work performed by the employee for the employer.

 

	 	b.	To
    the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from
    being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.

 

    	Page 22 of 22celu-ex1025_196.htm

Exhibit 10.25

 

THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS (A) THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, AND APPLICABLE STATE SECURITIES LAWS, COVERING ANY SUCH TRANSACTION INVOLVING SAID SECURITIES, (B) THE COMPANY RECEIVES AN OPINION OF LEGAL COUNSEL FOR THE HOLDER OF THESE SECURITIES SATISFACTORY TO THE COMPANY STATING THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION, OR (C) THE COMPANY OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION.  

Date of Issuance:  March 16, 2020 

FORM OF WARRANT TO PURCHASE SERIES B PREFERRED STOCK OF 

CELULARITY INC. 

For value received, Celularity Inc., a Delaware corporation (the “Company”), hereby grants to [_________] (“Holder”), this Warrant to purchase that number of shares of the Company’s Series B Preferred Stock as set forth in Section 2(b) hereof, as may be adjusted from time to time pursuant to Section 13 hereof.   

	
 
	
1.
	
Definitions.   

(a)“Act” shall mean the Securities Act of 1933, as amended. 

(b)“Business Days” shall mean any day other than a Saturday, a Sunday or any other 

day on which the Federal Reserve Bank of New York is required by Law to be closed. 

(c)“Change of Control” shall mean a transaction or a series of related transactions involving (i) a consolidation or merger of the Company which results in the stockholders of the Company immediately prior to the transaction owning less than a majority of the equity or voting power of the surviving entity, (ii) the sale, transfer or lease of all or substantially all of the Company’s assets taken as a whole together with any assets of the Company’s subsidiaries, whether by merger, consolidation or otherwise, and whether in a single transaction or a series of related transactions, (iii) the grant of an exclusive license to all or substantially all of the Company’s intellectual property that is used to generate all or substantially all of the Company’s revenues, or (iv) any sale of all or substantially all of the Company’s equity or any other transaction which results in the stockholders of the Company immediately prior to the transaction owning less than a majority of the equity or voting power of the surviving entity but not including any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or indebtedness of the Company is cancelled or converted (or a combination thereof). 

(d)“Common Stock” shall mean the Common Stock, par value $0.0001 per share, of the Company.  

(e)“Initial Public Offering” means the first firm commitment underwritten public 

 

 

 

offering of securities of the Company pursuant to an effective registration statement under the Act (other than a registration statement relating either to a sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar plan or an SEC Rule 145 transaction). 

(f)“Investors’ Rights Agreement” means that certain Amended and Restated Investors’ Rights Agreement, dated as of March 16, 2020, by and among the Company, Holder and the other parties thereto, as amended and/or restated from time to time.  

(g)“Restated Certificate” shall mean the Company’s Amended and Restated Certificate of Incorporation as of the date hereof, as amended and/or restated from time to time. 

(h)“Series B Preferred Stock” shall mean the Series B Preferred Stock, par value $0.0001 per share, of the Company. 

(i)“Stock Purchase Agreement” shall mean that certain Series B Preferred Stock Purchase Agreement, dated as of March 16, 2020, by and among the Company and the Investors listed on Schedule A, thereto. 

(j)“Voting Agreement” means that certain Amended and Restated Voting Agreement, 

dated as of March 16, 2020, by and among the Company, Holder and the other parties thereto, as amended and/or restated from time to time.  

(k)“Warrant” as used herein shall include this warrant (as the same may be amended 

from time to time) and any warrants delivered in substitution or exchange therefor as provided herein. 

	
 
	
2.
	
Exercise Amount and Price.   

(a)The exercise price per share (the “Exercise Price”) at which this Warrant will be 

exercised shall be $5.787. 

(b)This Warrant is exercisable for the purchase of [_________] shares of Series B Preferred Stock (as such number may be adjusted from time to time pursuant to Section 13 hereof). 

3.Term.  Subject to the terms and conditions set forth herein, the Holder may exercise this Warrant, in whole or in part, during the term commencing on the date hereof and ending at 5:00 p.m. (Eastern Time) on the first to occur of (a) the 60-month anniversary of the date of issuance of this Warrant written above, (b) the consummation of the Company’s Initial Public Offering, (c) the consummation of a Change of Control.  The Company will give Holder not less than twenty (20) days’ advance written notice of a transaction listed in Sections 3(b) through 3(c) hereof.   

4.Exercise of Warrant.  The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time, or from time to time, during the term hereof as described in Section 3 above, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly completed and executed on behalf of the Holder, at the principal offices of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder), upon payment in cash or by check acceptable to the Company of the Exercise Price of the shares to be purchased.  

 

 

 

 

 

5.Representations and Warranties of the Company.  The Company hereby represents and warrants to Holder that the following representations and warranties are true and correct: 

(a)Organization, Good Standing and Qualification.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted.  The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties. 

(b)Authorization.  All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization, execution and delivery of this Warrant, the performance of all obligations of the Company hereunder and thereunder, and the reservation for issuance, sale and delivery of the Series B Preferred Stock and the shares of Common Stock to be issued upon conversion of the Series B Preferred Stock issued in connection with the exercise of this Warrant (the “Conversion Shares”) has been taken.  This Warrant constitutes the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies. 

(c)Valid Issuance of Preferred and Common Stock.  The Series B Preferred Stock for which the Warrant is exercisable, when issued, sold and delivered in accordance with the terms of this Warrant for the consideration expressed herein, will be duly and validly issued, fully paid, and nonassessable, and will be free of restrictions on transfer other than restrictions on transfer under this Warrant, the Investors’ Rights Agreement and the Voting Agreement and under applicable state and federal securities laws or liens or encumbrances created by or imposed by Holder.  The Conversion Shares have been duly and validly reserved for issuance as of the date hereof and, upon issuance in accordance with the terms of the  Restated Certificate, will be duly and validly issued, fully paid, and nonassessable and will be free of restrictions on transfer other than restrictions on transfer under this Warrant, the Investors’ Rights Agreement and the Voting Agreement of the Company, each as amended and restated and currently in effect, and under applicable state and federal securities laws. 

(d)Governmental Consents.  No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority on the part of the Company is required in connection with the issuance or exercise of this Warrant, except for (i) such federal and state securities filings as may be necessary, which filings will be timely effected after the date hereof and (ii) such other approval that has been obtained prior to the date hereof. 

(e)Reliance by Holder.  The Company understands that the representations, warranties, covenants and acknowledgements set forth in this Section 5 constitute a material inducement to Holder entering into this Warrant. 

6.Representations and Warranties of Holder.  Holder hereby represents and warrants to the Company that the following representations and warranties are true and correct: 

(a)Purchase Entirely for Own Account.  This Warrant is being entered into for investment for Holder’s own account not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and Holder has no present intention of selling, granting any participation in, or otherwise distributing the same.  The acquisition by Holder of this Warrant shall constitute confirmation of the representation by Holder that it does not have any contract, undertaking, agreement or arrangement 

 

 

 

with any person to sell, transfer or grant participations to such person or to any third person, with respect to this Warrant. 

(b)Investment Experience.  Holder is an investor in securities of companies in the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of entering into this Warrant.  Holder acknowledges that the acquisition of shares of Series B Preferred Stock pursuant to this Warrant involves a high degree of risk, and represents that it is able, without materially impairing its financial condition, to hold such shares for an indefinite period of time and to suffer a complete loss of its investment.  Holder acknowledges that the Company has not made any representations or warranties as to whether the Exercise Price to be paid by Holder for the Series B Preferred Stock is a fair value for such shares and the Company takes no position with respect to the fairness of the Exercise Price or the future prospects and valuation of the Company.  Holder is aware of the fact that the value of the Series B Preferred Stock to be purchased upon exercise of this Warrant may significantly depreciate over time and there can be no assurances that the value of such shares will increase or to what extent.  In connection with making an investment decision in connection with entering into this Warrant, Holder will be relying on its own knowledge and experience and advice obtained from Holder’s legal, tax and financial advisor 

(c)Accredited Investor.  Holder is an “accredited investor” within the meaning of SEC Rule 501 of Regulation D, as presently in effect. 

(d)Restricted Securities.  Holder understands that this Warrant, as well as the Series B Preferred Stock to be purchased upon exercise hereof, are and will be characterized as “restricted securities” under the federal securities laws inasmuch as they are and will be acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Act only in certain limited circumstances.  In this connection, Holder represents that it is familiar with SEC Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Act.  HOLDER UNDERSTANDS AND ACKNOWLEDGES HEREIN THAT AN INVESTMENT IN THE COMPANY’S SECURITIES INVOLVES AN EXTREMELY HIGH DEGREE OF RISK AND MAY RESULT IN A COMPLETE LOSS OF ITS INVESTMENT.  Holder understands that neither this Warrant nor the shares of Series B Preferred Stock to be purchased upon exercise of this Warrant have been or will be registered under the Act and have not been and will not be registered or qualified in any state in which they are offered, and thus the Holder will not be able to resell or otherwise transfer this Warrant or the shares of Series B Preferred Stock issued upon exercise of this Warrant unless they are registered under the Act and registered or qualified under applicable state securities laws, or an exemption from such registration or qualification is available.  Holder has no immediate need for liquidity in connection with this investment, and does not anticipate that Holder will be required to sell this Warrant or the shares of Series B Preferred Stock issued upon exercise of this Warrant in the foreseeable future. 

(e)Legends.  It is understood that the certificates, if any, evidencing the shares of Series B Preferred Stock issuable upon exercise of this Warrant may bear one or all of the following legends, in addition to any other legends that may be set forth in agreements to which the Holder is a party: 

(i)“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER 

 

 

 

SUCH ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT.” 

(ii)Any legend required by applicable state securities laws. 

(f)Reliance by Company.  Holder understands that the representations, warranties, covenants and acknowledgements set forth in this Section 6 constitute a material inducement to the Company entering into this Warrant. 

(g)Foreign Investors.  Holder hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with entering into this Warrant, including (i) the legal requirements within its jurisdiction for entering into this Warrant and the exercise of this Warrant, (ii) any foreign exchange restrictions applicable to the exercise of this Warrant, (iii) any governmental or other consents that may need to be obtained, including with respect to the payment of the Exercise Price at the applicable Closing, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of this Warrant or the shares of Series B Preferred Stock issuable upon exercise hereof.  The Holder’s acquisition of this Warrant and payment for the Series B Preferred Stock upon exercise of this Warrant and continued beneficial ownership of such shares will not violate any applicable securities or other laws of the Holder’s jurisdiction. 

7.No Fractional Shares.  No fractional share of any class or series of the Company’s capital stock shall be issued upon exercise of this Warrant.  

8.Replacement of Warrant.  On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and (a) in the case of loss, theft, or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or (b) in the case of mutilation, on surrender and cancellation of this Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.  The Holder shall reimburse the Company for all reasonable expenses incidental to replacement of this Warrant. 

9.Rights of Stockholder.  This Warrant shall not entitle its holder to any of the rights of a stockholder of the Company until this Warrant shall have been exercised and the shares of Series B Preferred Stock purchasable upon the exercise hereof shall have been issued. 

10.Warrant Not Transferable.  This Warrant and the rights hereunder are not transferable and/or assignable, in whole or in part, by any party without the consent of the other party.  Any transferee of the Holder, if not already a party thereto, shall, promptly following such transfer or assignment, deliver the duly signed joinders to the Company’s then-effective Investors’ Rights Agreement and Voting Agreement.  Any purported assignment in violation of this Warrant shall be void.  Notwithstanding the foregoing, Holder may not transfer this Warrant to any person or entity that the Company, in its reasonable discretion, determines to be a competitor of the Company.  

11.Notice of Certain Events.  Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 13 hereof and if so requested by Holder, the Company shall issue a certificate signed by its Chief Financial Officer, or other similar officer, setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated and the Exercise Price and number of shares purchasable hereunder after giving effect to such adjustment and shall cause a copy of such certificate to be mailed (by first class mail, postage prepaid) to the Holder of this Warrant. 

 

 

 

12.Amendments; Waivers. 

(a)The provisions of this Warrant may be amended (either generally or in a particular instance and either retroactively or prospectively), only by an instrument in writing signed by the Company and the holders of warrants to acquire at least a majority of the aggregate shares of capital stock then issuable upon exercise of all Starr Warrants (as defined in the Stock Purchase Agreement); provided, however, that any such amendment that materially and adversely affects the Holder in a manner different from the other holders of Starr Warrants shall require the separate consent of the Holder hereof.  In addition, subject to the proviso in the preceding sentence, Holder agrees that such Holder’s rights hereunder may be waived or amended by persons or entities holding Starr Warrants to acquire at least a majority of the aggregate shares of capital stock issuable upon exercise of all Starr Warrants without obtaining any additional consents of the Holder.  The foregoing shall not limit or otherwise affect Holder’s right to waive any of such Holder’s rights hereunder with respect to itself without obtaining the consent of any other holder of the Series B Warrants.  Any amendment or waiver effected in accordance with this Section 12(a) shall be binding upon Holder and Holder’s successors and assigns.  

(b)No waivers of or exceptions to any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition or provision. 

13.Adjustments.  The Exercise Price and the number and type of shares purchasable hereunder are subject to adjustment from time to time as follows: 

(a)Conversion of Preferred Stock.  Should prior to the expiration of this Warrant, all of the Company’s Series B Preferred Stock be, or if outstanding would be, converted into shares of the Company’s Common Stock in accordance with the Restated Certificate, then this Warrant shall immediately become exercisable for that number of shares of the Common Stock which would have been received if this Warrant had been exercised in full and the Series B Preferred Stock received thereupon had been simultaneously converted immediately prior to such event, and the Exercise Price shall be immediately adjusted to equal the quotient obtained by dividing (i) the aggregate Exercise Price of the maximum number of shares of the Series B Preferred Stock for which this Warrant was exercisable immediately prior to such conversion, by (ii) the number of shares of Common Stock for which this Warrant is exercisable immediately after such conversion.   

(b)Reclassification, etc.  If, at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company shall, by reclassification of securities or otherwise, change any of the securities as to which purchase rights under this Warrant exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 13; provided, however, that the aggregate Exercise Price shall remain the same. 

(c)Split, Subdivision or Combination of Shares.  If at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the Company shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the Exercise Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination.  Upon an adjustment in the Exercise Price pursuant to this Section 13(c), the number of shares subject to this Warrant (which 

 

 

 

were the subject of such split, subdivision or combination) shall be adjusted accordingly such that the aggregate Exercise Price payable for the purchase of such shares shall remain the same as before such split, subdivision or combination. 

(d)Adjustments for Dividends in Stock or Other Securities or Property.  If at any time on or after the date hereof and while this Warrant remains outstanding and unexpired, the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or on or after the record date fixed for the determination of eligible stockholders shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend or other distribution in respect of the Series B Preferred Stock, then, and in each case, this Warrant shall represent the right to acquire, in addition to the number of shares of the security receivable upon exercise of this Warrant and without payment of any additional consideration therefor, the amount of such other or additional stock or other securities or property (other than cash) of the Company which such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this Section 13, and, from and after the date of such distribution, the Company shall hold and set aside (or cause to be held and set aside in a commercially reasonable manner) an amount of such property equal to Holder’s pro rata portion thereof for distribution to Holder pursuant hereto. 

14.Reservation of Capital Stock. The Company hereby covenants that at all times following the date hereof there shall be reserved for issuance and delivery upon exercise of this Warrant such number of shares of Series B Preferred Stock as are from time to time issuable upon exercise of this Warrant and such number of the shares of Common Stock as are from time to time issuable upon conversion of the shares of Series B Preferred Stock which are subject to this Warrant. 

15.Miscellaneous. 

(a)Survival of Representations, Warranties and Covenants.  The warranties, representations and covenants of each party hereto contained in or made pursuant to this Warrant shall survive the execution and delivery of this Warrant and shall in no way be affected by any investigation of the subject matter thereof made by or on behalf of the Holder or the Company, as applicable. 

(b)Titles and Subtitles.  The titles and subtitles used in this Warrant are used for convenience only and are not to be considered in construing or interpreting this Warrant. 

(c)Governing Law.  This Warrant is to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties.  All disputes and controversies arising out of or in connection with this Warrant shall be resolved exclusively by the state or federal courts located within the City of Wilmington in the State of Delaware, and each party hereto agrees to submit to the jurisdiction of said courts and agrees that venue shall lie exclusively with such courts. 

(d)Waiver of Right to Jury Trial.  EACH OF HOLDER AND THE COMPANY, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS WARRANT. 

 

 

 

(e)Notices.  Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Warrant shall be in writing and shall be conclusively deemed to have been duly given (i) when hand delivered to the other party; (ii) when sent by email or facsimile if sent between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day, or on the next business day if sent by email or facsimile other than between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day; (iii) seven business days after deposit in the U.S. mail with first class or certified mail receipt requested postage prepaid and addressed to the other party; or (iv) the next business day after deposit with an international overnight delivery service, postage prepaid, addressed to the parties with next business day delivery guaranteed, provided that the sending party receives a confirmation of delivery from the delivery service provider.  Each person making a communication hereunder by email  or facsimile shall promptly confirm by telephone between 8:00 a.m. and 5:00 p.m. recipient’s local time on a business day to the person to whom such communication was addressed each communication made by it by email or facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication.  All communications shall be sent to the address, email address or facsimile number of a party appearing in its signature block hereto or at such address, email address or facsimile number as such party may designate by ten (10) days advance written notice to the other parties hereto. 

(f)Specific Performance.  Each party hereto acknowledges and agrees that any breach of this Warrant would result in substantial harm to the other party hereto for which monetary damages alone could not adequately compensate.  Therefore, the parties hereto unconditionally and irrevocably agree that any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and other remedies available at law or in equity (including, without limitation, seeking specific performance).  

(g)Counterparts.  This Warrant may be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g. www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

 

 

[Remainder of Page Intentionally Left Blank] 

 

 

 

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the Date of Issuance indicated above. 

 

	
CELULARITY INC.

	
a Delaware corporation

	
By:
	
 
	
 

	
Name:
	
 
	
Robert J. Hariri, M.D., Ph.D.

	
Title:
	
 
	
Founder, CEO and President

 

	
Address:
	
 
	
33 Technology Drive South

	
 
	
 
	
Warren, New Jersey 07059

 

 

 

 

 

ACTIVE/113392616.2 

 

 

 
 

 

 

ACKNOWLEDGED AND AGREED:

 

 

	
HOLDER

	
 
	
 
	
 

	
[_________]

	
 
	
 
	
 

	
By:
	
 
	
 

	
Name:
	
 
	
 

	
Title:
	
 
	
 

	
 

	
Address for notice

	
 

[_________]

	
 
	
 
	
 

	
with a copy to:

	
 

[_________]
	
 
	
 

 

 

 

 

[Signature Page to Warrant]

ACTIVE/113392616.2 

 

 

 
 

 

 

NOTICE OF EXERCISE

 

 

	
To: 
	
Celularity Inc. 

33 Technology Drive 

Warren, New Jersey 07059 

 

 

The undersigned (“Holder”), pursuant to the provisions set forth in the Warrant to Purchase Series B Preferred Stock dated March 16, 2020 (the “Warrant”) hereby elects to purchase shares of the Series B Preferred Stock (as defined in the Warrant) pursuant to the terms of the Warrant, and tenders herewith payment of the purchase price for such shares in full. 

 

 

	
 
	
 
	
 

	
 
	
 
	
[Print Name]

	
 
	
 
	
 

	
 
	
 
	
 

	
[Date]
	
 
	
[Signature]

	
 
	
 
	
 

 

 

 

NAI-1511984614v2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]